Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Betsson granted online sports betting license in Germany

Betsson has applied for and received clearance from Darmstadt Regional Council to operate online sports betting throughout Germany. Besides the sports betting licenses which have now been granted, the New Interstate Treaty, which paves the way for the regulation and opening up of the market for online slots and poker in Germany, is scheduled to come into force on 1 July 2021. “We are pleased to finally receive this license and we are preparing to re-launch our German Sportsbook shortly under the German regulation. Operating sports betting in Germany is part of our strategy of

Etrion to Release 2020 Results

March 11, 2021, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, will release its fourth quarter and year end 2020 results after the market closes on Friday, March 12, 2021.   Operations and Finance Update call  A conference call webcast to present the Company’s 2020 Operations and Finance update will be held on Monday, March 15, 2021, at 11:00 a.m. Eastern Standard Time (EST) / 4:00 p.m. Central European Time (CET).   Dial-in details: Conference ID: 2598191 North America: +1-647-788-4919 / Toll

Herantis Pharma Announces an Oral Presentation and a Poster Presentation related to First-in-Man CDNF Clinical Trial at AD/PD™ Virtual Conference

Herantis Pharma Plc Company Press Release, 11 March 2021 at 08:00 a.m. EET Herantis Pharma Plc (“Herantis”), an innovative clinical stage biotech company pioneering new disease modifying and regenerative biologic and gene therapies, announced today that the company will be presenting an oral presentation and a poster presentation summarizing the results from the Phase I-II First-In-Man Clinical Trial of CDNF in Parkinson’s Disease at the 15[th] International Conference on Alzheimer’s and Parkinson’s Diseases, AD/PD™ 2021 Virtual Conference, March 9-14, 2021. The oral presentation

Healthy Diet Index supports diet quality assessment and dietary counselling in healthcare

The Healthy Diet Index developed by Finnish nutrition experts facilitates the assessment of diet quality. Its effectiveness was demonstrated in a recently published study. Dietary counselling plays a crucial role in the prevention and treatment of chronic lifestyle diseases. In healthcare settings, dietary counselling is often provided by professionals without specific training in nutrition, and there is a demand for tools for reliable and easy assessment of diet quality.  One such tool is the Healthy Diet Index developed in the recently completed Stop Diabetes (StopDia) project. The

Diös acquires two properties in Gävle

Diös has acquired two properties in Gävle: one is a new office building in the fast-growing Ersbo area, and the other building is made up of offices and other commercial businesses, strengthening the company’s existing portfolio in Alderholmen. The agreed property value amounts to SEK 103 million. The seller is Ersand Invest and transfer of ownership will take place on 1 April 2021. The properties in Ersbo and Alderholmen.Ersbo is expanding rapidly and Diös sees great development potential in the area through offices and urban services. The acquisition of the property in

Azelio has completed a directed share issue of approximately SEK 596 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES.The Board of Directors of Azelio AB (publ) (“Azelio” or the “Company”) has, based on the authorization given by the annual general meeting on 14 May 2020, resolved on a directed issue of 10,638,225 new shares, corresponding to approximately 10 percent of the total number of

RNB TO SELL POLARN O. PYRET TO PROCURITAS

RNB Retail and Brands AB (publ) has today reached an agreement to sell Polarn O. Pyret to Procuritas for a preliminary value of SEK 330 million on a cash and debt-free basis. RNB Retail and Brands AB has previously announced a process to separate the group subsidiaries and ultimately divest the subsidiaries to stable and suitable owners. After the divestment of the business of Departments & Stores earlier this year, one such process has now reached an important milestone with the agreement to divest the assets of Polarn O. Pyret to Procuritas Fund VI. The preliminary purchase price

Storytel has completed a directed share issue and thereby raises approximately SEK 1,171 million

INSIDE INFORMATION: The Board of Directors of Storytel AB (publ) (“Storytel” or the “Company”) has, in accordance with the announcement made in a press release earlier today, successfully completed a directed issue of 5,370,000 shares corresponding to approximately SEK 1,171 million (the “Directed Issue”). The subscription price in the Directed Issue was set at 218 SEK per share and was determined through an accelerated book building procedure performed by ABG Sundal Collier and Swedbank AB (publ). The Directed issue was significantly oversubscribed. A large number of Swedish and

NOTICE TO THE ANNUAL GENERAL MEETING OF NANOFORM FINLAND PLC

Company Announcement Nanoform Finland Plc March 10, 2021 23:00 Finnish time / 22:00 Swedish time   Notice to the Annual General Meeting of NANOFORM FINLAND Plc The shareholders of Nanoform Finland Plc (the “Company”) (business ID: 2730572-8) are hereby invited to the Annual General Meeting to be held on 6 April 2021 (EET) at 10:00am at Viikinkaari 4, FI-00790 Helsinki, Finland (“AGM”). The Board of Directors of the Company has resolved on the exceptional procedure for the meeting based on the temporary legislative act to limit the spread of the Covid-19 pandemic (677/

Mandatory Notification of Trade - Options

Reference is made to the announcement on 22 May, 2018, in which Hexagon Composites ASA (the "Company") announced the grant of 1,200,000 share options to employees under its employee share option program, each at a strike price of NOK 20.85 per share. Following the spin-off of Purus and resultant distribution of a dividend in kind amounting to 15% of that company, the strike price has been adjusted by the fair market value of NOK 4.095 essentially to “make whole” all 2018 options holders. The new strike price is therefore NOK 16.80 per share. Of the 1,200,000 options, 800,000 options were

Trade subject to notification - treasury shares week 10 2021

Orkla ASA has in the period 8 March to 9 March 2021 bought 840,000 Orkla shares through broker at an average price of NOK 82.04 per share. Orkla's total holding of treasury shares after this is 5,501,800 shares. The share buy-back programme which was initiated on 22 February 2021 is now completed. Please refer to appendix for further details. The appendices can also be viewed on www.newsweb.no.   Orkla ASAOslo, 10 March 2021  Ref.:SVP Investor RelationsKari LindtvedtTel.: +47 950 75 114

Magnolia Bostad issues new senior unsecured green bonds of SEK 500 million

Magnolia Bostad AB (publ) ("Magnolia Bostad") has successfully issued four year senior unsecured floating rate green bonds in an amount of SEK 500 million under a framework of up to SEK 1,000 million.The new bonds are due in March 2025 and carries a floating interest rate of STIBOR 3m plus 6.90 per cent and the transaction was heavily oversubscribed. Magnolia Bostad intends to list the new bonds on the sustainable bond list of Nasdaq Stockholm. An amount equivalent to the net proceeds from the bond issue will be applied in accordance with the principles set out in Magnolia Bostad’s Green

Notice to Stockmann’s Annual General Meeting

STOCKMANN plc, Notice to general meeting 10 March 2021 at 20:00 EET Notice is given to the shareholders of Stockmann plc (the “Company”) to the Annual General Meeting to be held on Wednesday 7 April 2021 at 14:00 at the premises of Roschier, Attorneys Ltd. in Helsinki at the address Kasarmikatu 21 A. Shareholders and their proxy representatives may participate in the meeting and exercise their rights only by voting in advance and by making counterproposals and presenting questions in advance in accordance with this notice and other instructions by the Company. Participation at the

Catena Media announces the outcome of the exercise of warrants during post Q4 2020 report subscription period

Catena Media plc (Nasdaq Stockholm: CTM)  Catena Media plc (“Catena Media” or the “Company”) today announces the outcome of the subscription period following the publication of the financial report for the fourth quarter 2020 of the warrants 2020/2024 (“Warrants”) issued as part of the rights issue of units.In total, 1,351,582 Warrants, corresponding to approximately 3.6 per cent. of all outstanding Warrants (being approximately 2.9 per cent. of all Warrants issued as part of the rights issue), were used to subscribe for the same number of new ordinary shares in the Company. Payment for

Ahlstrom-Munksjö’s Annual General Meeting postponed

AHLSTROM-MUNKSJÖ OYJ STOCK EXCHANGE RELEASE March 10, 2021 at 18:45 EET Ahlstrom-Munksjö’s Annual General Meeting (AGM) will be postponed until a date to be separately announced. The AGM was initially planned to be held on March 24, 2021. The Board of Directors of Ahlstrom-Munksjö will decide on a new date for the AGM and give notice to convene the AGM in due course. The AGM shall convene no later than by June 30, 2021. As previously announced, Spa Holdings 3 Oy has acquired through a public tender offer more than 90 per cent of all the issued and outstanding shares and votes in

Storytel intends to carry out a directed share issue through an accelerated book building process

INSIDE INFORMATION: Storytel AB (publ) (“Storytel” or the “Company”) intends to carry out a directed issue of up to approximately 5.4 million shares through an accelerated book building procedure (the “Directed Issue”). The Directed Issue will be directed to Swedish and international institutional investors. The proceeds from the Directed Issue will inter alia be used for the Company’s accelerated investments in content production, sales and marketing as well as to finance potential future acquisition opportunities in accordance with the Company’s communicated expansionary strategy. Storytel

Azelio intends to carry out a directed share issue of up to approximately 10.6 million shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES.Azelio AB (publ) (“Azelio” or the “Company”) hereby announces its intention to, based on the authorization given by the annual general meeting on 14 May 2020, carry out an issue of shares of up to approximately 10.6 million shares, directed to Swedish and international institutional

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 10.03.2021

United Bankers Corporation NOTIFICATION 10.03.2021 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 10.03.2021 Date 10.03.2021Exchange transaction BuyShare class UNIAVAmount 827Average price/share 12.8346 EURHighest price/share 12.9000 EURLowest price/share 12.8000 EURTotal price 10,614.21 EUR The shares held by United Bankers Corporation on 10.03.2021: UNIAV 52,211   On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti

Solteq Plc: Correction to the notice to Annual General Meeting 2021

Stock Exchange Bulletin, March 10, 2021, at 6 p.m.In the notice to the Annual General Meeting of Solteq Plc published on 9 March 2021 at 10.45, the weekday for the meeting was incorrect. The Annual General Meeting is to be held on Tuesday 30 March 2021. Below the corrected to notice to Annual General Meeting 2021: Shareholders of Solteq Plc are hereby invited to the Annual General Meeting (the “General Meeting”) to be held on Tuesday 30 March 2021 at 10 a.m. at Solteq’s headquarters, address Karhumäentie 3, 01530 Vantaa. The shareholders of the company and their proxy

Calmark signs distributor agreement with Enox Pharma for five key markets in the Middle East

Calmark Sweden AB (publ) has today entered an exclusive distributor agreement with the company Enox Pharma AB regarding marketing and sales of Calmark's products in the countries Egypt, Iraq, Bahrain, Saudi Arabia and the United Arab Emirates. Through this agreement, Calmark expands its launch in the MENA region, where there is an extensive need for safe and effective diagnostics.Enox Pharma is a Swedish company specializing in the distribution of life science products and related services between Europe and the MENA region. The company sells innovative, sustainable and efficient solutions

Three reasons why a rectifier from KraftPowercon is a good choice

Aftersales & Service are natural parts of our day-to-day work, as it ensures our customers’ operational capacity throughout our products’ entire life cycle. That is why we keep track of our installations and offer rapid and efficient support if our customers find themselves in a situation where they need it. Ballast water management systems are complex systems that require technical expertise and know-how to maintain. They are also comprised of several different parts that need to work faultlessly under any circumstance. This is especially true for the rectifier, which supplies the

BioStock: Aptahem's CEO on signing of non binding Term Sheet

Aptahem announced yesterday that the company has entered into a non binding Term Sheet (NBTS) with a European pharmaceutical company. The NBTS relates to license terms for the exclusive development, manufacturing and distribution of Apta-1 for the treatment of sepsis in Europe. BioStock reached out to CEO Mikael Lindstam to learn more.Read the full interview with Mikael Lindstam at biostock.se: https://www.biostock.se/en/aptahems-ceo-on-signing-of-non-binding-term-sheet/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

There are no items matching the current filter
There are no more items matching the current filter
Back to top